In a compelling call to action echoed across European policy circles, Professor Anna Gilmore, a distinguished expert in public health and Co-Director of the Centre for 21st Century Public Health at the University of Bath, urges governments to take decisive regulatory action against powerful commercial sectors detrimental to climate and public health. Her appeal comes in the wake of a groundbreaking report released by the Pan-European Commission on Climate and Health, convened by the World Health Organization (WHO). This report meticulously dissects how entrenched commercial interests obstruct meaningful progress in climate mitigation and public health, highlighting a critical intersection that demands urgent and unified intervention.
Professor Gilmore’s authoritative analysis underscores a fundamental truth: the forces driving environmental degradation and those harming human health are not discrete issues but are integrally linked, upheld by identical corporate behaviors and strategies. Industries such as fossil fuels, ultra-processed foods, alcohol, and tobacco wield considerable influence, systematically employing tactics designed to mislead scientific discourse, capture regulatory bodies, and lobby against effective legislation. These practices perpetuate a cycle wherein corporate profits are prioritized over climate sustainability and population well-being, hindering transformative policies and interventions.
The report dismantles the efficacy of voluntary initiatives and public-private partnerships touted by commercial actors, framing them instead as corporate strategies that deftly mask conflicts of interest and dilute accountability. Professor Gilmore cautions that self-regulation or government collaborations with these industries offer an illusion of progress while often entrenching corporate agendas within public policy frameworks. She draws parallels to the historical trajectory of tobacco control, where robust binding regulations and the protection of policymaking from corporate interference were instrumental in achieving public health victories.
From an economic standpoint, Professor Gilmore challenges the pervasive narrative that regulation imposes undue burdens on economic growth. She elucidates that the true economic calculus must incorporate the extensive costs inflicted by commercially driven climate and health damage—costs that far outweigh those associated with proactive regulatory measures. The report advocates for governments to rescind harmful subsidies, realign fiscal and trade policies with climate and health goals, and insulate policy processes from corporate capture, thereby fostering resilient systems that prioritize societal welfare.
Integral to this discourse is the imperative of governance innovation, where transparency, accountability, and independent monitoring form the pillars of effective public health and environmental policy. Professor Gilmore argues that rebuilding regulatory frameworks—rooted in empirical evidence and free from corporate distortion—is paramount to curbing the influence wielded by multinational corporations across sectors. This reimagined governance architecture, she asserts, will be critical to balancing the power asymmetry between global corporate entities and public authorities.
Professor Gilmore’s contributions to the WHO Pan-European Commission illustrate a rigorous examination of the systemic barriers that commercial determinants pose to health equity and environmental protection. Her work, supported by the WHO Council on the Economics of Health for All, identifies recurring corporate tactics including the manufacture of doubt through skewed scientific research, systematic lobbying to weaken regulatory efforts, and leveraging corporate social responsibility to evade stringent oversight. This engagement provides a comprehensive blueprint for deconstructing corporate interference and enhancing public policy integrity.
The conceptual framework underpinning Professor Gilmore’s advocacy reveals how commercial interests exploit regulatory loopholes and fragment policymaking processes to preserve business as usual. Her insights extend beyond criticism, outlining constructive pathways for governments to enact binding regulations that align economic activities with the urgent imperatives of climate resilience and public health promotion. This paradigm shift is posited as not merely desirable but essential for the sustainability of future generations and planetary ecosystems.
At the heart of these findings lies the pivotal assertion that effective regulation must transcend incrementalism and voluntary compliance. Professor Gilmore emphasizes that enforceable, transparent, and science-driven policies are indispensable to dismantling the entrenched influence of multinational corporations, thereby catalyzing systemic change. This position aligns with a growing global consensus that sustainable development strategies must integrate stringent oversight of commercial determinants to realize equitable health outcomes and safeguard environmental integrity.
Furthermore, Professor Gilmore situates her research within broader multidisciplinary collaborations, including the Local Health Global Profits consortium, which unites leading UK research institutions to interrogate and address commercial determinants at the municipal governance level. This integrative approach highlights the vital role of localized policy interventions in complementing national and international regulations, underscoring the complexity and scale of the challenge.
Expertise in public health policy, environmental governance, and climate action converge in Professor Gilmore’s innovative research agenda, positioning her at the forefront of efforts to reconceptualize the relationship between economic development and planetary health. Her urgent message to European policymakers encapsulates a transformative ethos: that safeguarding health and climate for present and future generations hinges on disentangling policy frameworks from the undue influence of powerful commercial actors.
In sum, Professor Anna Gilmore’s evidence-based advocacy and comprehensive critique presented to the Pan-European Commission on Climate and Health illuminate a critical path forward—one in which governments must adopt rigorous regulatory frameworks to confront and mitigate the pervasive influence of commercial determinants. This public health and environmental imperative demands immediate, integrated policy action to align economic systems with the profound challenges of climate change and human well-being, marking a potentially decisive turning point in Europe’s response to these intertwined crises.
Subject of Research: Commercial determinants of health, climate policy, and public health governance
Article Title: Leading Public Health Expert Calls for Regulatory Revolution to Tackle Climate and Health Crises in Europe
News Publication Date: 17 May 2026
Web References:
- Pan-European Commission on Climate and Health report: https://www.who.int/europe/groups/pan-european-commission-on-climate-and-health
- Local Health Global Profits (LHGP): https://www.phiuk.org/local-health-global-profits
Image Credits: Laurie Lapworth / University of Bath
Keywords: Public policy, Climate policy, Environmental policy, Health care policy, Regulatory affairs, Commercial determinants of health, Public health governance, Sustainability, Tobacco control, Fossil fuel industry, Corporate influence, Climate and health integration
